keyword
https://read.qxmd.com/read/38462929/deciphering-the-mechanism-of-siwu-decoction-inhibiting-liver-metastasis-by-integrating-network-pharmacology-and-in-vivo-experimental-validation
#21
JOURNAL ARTICLE
Xuelei Chu, Feiyu Xie, Chengzhi Hou, Xin Zhang, Sijia Wang, Hongting Xie, Chen An, Ying Li, Leyi Zhao, Peng Xue, Shijie Zhu
BACKGROUND: Siwu Decoction (SWD) is a well-known classical TCM formula that has been shown to be effective as a basis for preventing and reducing liver metastases (LM). However, the active ingredients and potential molecular mechanisms remain unclear. OBJECTIVE: This study aimed to systematically analyze the active ingredients and potential molecular mechanisms of SWD on LM and validate mechanisms involved. MATERIALS AND METHODS: The active ingredients in SWD were extracted by UHPLC-MS/MS in a latest study...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/38462923/management-of-treatment-na%C3%A3-ve-diabetic-macular-edema-patients-review-of-real-world-clinical-data
#22
REVIEW
Francesco Boscia, Daniele Veritti, Cristiana Iaculli, Rosangela Lattanzio, Simona Freda, Benedetta Piergentili, Monica Varano
The high prevalence of Diabetic macular edema (DME) is a real global health problem. Its complex pathophysiology involves different pathways. Over the last decade, the introduction of intravitreal treatments has dramatically changed the management and prognosis of DME. Among the different treatment options, inhibitors of vascular endothelial growth factor (anti-VEGF) and intravitreal steroids implants represent the first-line therapy of DME. We conducted a review of electronic databases to compile the available evidence about the clinical management of DME in a clinical setting, with a special focus on treatment-naïve patients...
March 11, 2024: European Journal of Ophthalmology
https://read.qxmd.com/read/38455663/doxazosin-inhibits-vasculogenic-mimicry-in-human-non%C3%A2-small-cell-lung-cancer-through-inhibition-of-the-vegf%C3%A2-a-ve%C3%A2-cadherin-mtor-mmp-pathway
#23
JOURNAL ARTICLE
Jui-Ling Hsu, Wohn-Jenn Leu, Lih-Ching Hsu, Chia-Hsun Hsieh, Jih-Hwa Guh
Lung cancer is the leading cause of cancer-related death worldwide, and ~85% of lung cancers are non-small cell lung cancer (NSCLC), which has a low 5-year overall survival rate and high mortality. Several therapeutic strategies have been developed, such as targeted therapy, immuno-oncotherapy and combination therapy. However, the low survival rate indicates the urgent need for new NSCLC treatments. Vasculogenic mimicry (VM) is an endothelial cell-free tumor blood supply system of aggressive and metastatic tumor cells present during tumor neovascularization...
April 2024: Oncology Letters
https://read.qxmd.com/read/38454277/gene-expression-array-analyses-predict-proto-oncogene-expression-during-perineural-invasion-in-pancreatic-ductal-adenocarcinoma
#24
JOURNAL ARTICLE
Shu Zhao, Zhen Xue, Jing Yao Wang, Peng Song
BACKGROUND/AIMS: Pancreatic ductal adenocarcinoma is the tumor type with the highest incidence of perineural invasion. This study tries to identify the differentially expressed genes regulated between pancreatic ductal adenocarcinoma tissues with perineural invasion and without perineural invasion. MATERIALS AND METHODS: The GSE102238 profile was downloaded. Gene function and pathway analysis were subsequently conducted. A protein-protein interaction network was constructed to search for hub genes...
January 2024: Turkish Journal of Gastroenterology: the Official Journal of Turkish Society of Gastroenterology
https://read.qxmd.com/read/38430807/siglec9%C3%A2-%C3%A2-tumor-associated-macrophages-predict-prognosis-and-therapeutic-vulnerability-in-patients-with-colon-cancer
#25
JOURNAL ARTICLE
Jiang Chang, Qingyang Feng, Yihao Mao, Zhiyuan Zhang, Yuqiu Xu, Yijiao Chen, Peng Zheng, Songbin Lin, Feifan Shen, Zhuojian Zhang, Ziqi Zhang, Guodong He, Jianmin Xu, Ye Wei
BACKGROUND: Siglec9 has been identified as an immune checkpoint molecule on tumor-associated macrophages (TAMs). Nevertheless, the expression profile and clinical significance of Siglec9 + TAMs in colon cancer (CC) are still not fully understood. METHODS: Two clinical cohorts from distinct medical centers were retrospectively enrolled. Immunohistochemistry and immunofluorescence were conducted to evaluate the infiltration of immune cells. Single-cell RNA sequencing and flow cytometry were utilized to identify the impact of Siglec9 + TAMs on the tumor immune environment, which was subsequently validated through bioinformatics analysis of the TCGA database...
March 1, 2024: International Immunopharmacology
https://read.qxmd.com/read/38428246/establishment-of-a-multi-strategy-platform-for-quality-control-and-quality-markers-screen-of-mailuoshutong-pill
#26
JOURNAL ARTICLE
Yaojuan Chu, Xiangyu Zhang, Lihua Zuo, Xiaobao Wang, Yingying Shi, Liwei Liu, Lin Zhou, Jian Kang, Bing Li, Wenbo Cheng, Shuzhang Du, Zhi Sun
Thromboangiitis obliterans (TAO) is a non-atherosclerotic segmental inflammatory occlusive disease with a high recurrence rate, high disability rate, difficulty to cure, and poor prognosis. It has been clinically proven that Mailuoshutong pill (MLSTP) is an effective traditional Chinese medicine for treating TAO. As MLSTP contains hundreds of chemical components, the quality control of which is a challenge in the development of reliable quality evaluation metrics. This study aimed to evaluate the quality uniformity of MLSTP by establishing a multi-strategy platform...
February 23, 2024: Journal of Pharmaceutical and Biomedical Analysis
https://read.qxmd.com/read/38415870/effect-of-chrdl1-on-angiogenesis-and-metastasis-of-colorectal-cancer-cells-via-tgf-%C3%AE-vegf-pathway
#27
JOURNAL ARTICLE
Junfeng Li, Zhongxiang Jiang, Jin He, Kun Yang, Jun Chen, Qianxi Deng, Xiaoqing Li, Fan Wu, Shuman Xu, Zheng Jiang
Colorectal cancer (CRC) is a common digestive tract tumor with the third incidence and death in the world. There is still an urgent need for effective therapeutic targets and prognostic markers for CRC. Herein, we report a novel potential target and marker, Chordin like-1 (CHRDL1). The function of CHRDL1 has been reported in gastric cancer, breast cancer, and oral squamous cell carcinoma. However, the biological effect of CHRDL1 in CRC remains unrevealed. Transwell and tube formation experiments were used to determine the biological function of CHRDL1...
February 28, 2024: Molecular Carcinogenesis
https://read.qxmd.com/read/38407373/immune-profiling-of-vulvar-squamous-cell-cancer-discovers-a-macrophage-rich-subtype-associated-with-poor-prognosis
#28
JOURNAL ARTICLE
Mateja Condic, Andrea Rohr, Soheila Riemann, Christian Staerk, Tiyasha H Ayub, Anna Doeser, Thomas Zillinger, Sabine Merkelbach-Bruse, Reinhard Buettner, Winfried Barchet, Christian Rudlowski, Alexander Mustea, Kirsten Kübler
The incidence rates of vulvar squamous cell cancer (VSCC) have increased over the past decades, requiring personalized oncologic approaches. Currently, lymph node involvement is a key factor in determining prognosis and treatment options. However, there is a need for additional immune-related biomarkers to provide more precise treatment and prognostic information. Here, we used immunohistochemistry and expression data to characterize immune cells and their spatial distribution in VSCC. Hierarchical clustering analysis identified distinct immune subtypes, of which the macrophage-rich subtype was associated with adverse outcome...
February 26, 2024: Cancer Res Commun
https://read.qxmd.com/read/38406066/spontaneous-massive-retinal-pigment-epithelium-tear-a-case-report-of-a-dramatic-complication-of-age-related-macular-degeneration
#29
Renato Correia Barbosa, Carla Teixeira
Retinal pigment epithelium (RPE) tears occur when the RPE acutely breaks and retracts, leaving the underlying Bruch's membrane and choroid exposed. They usually happen in areas of previous pigment epithelial detachments and are generally associated with age-related macular degeneration (AMD). The purpose of this report is to describe a case of a spontaneous massive central RPE tear in a patient with untreated AMD. A 67-year-old female patient presented with complaints of sudden decreased vision in her right eye...
January 2024: Curēus
https://read.qxmd.com/read/38398014/adverse-events-of-cabozantinib-as-a-potential-prognostic-factor-in-metastatic-renal-cell-carcinoma-patients-real-world-experience-in-a-single-center-retrospective-study
#30
JOURNAL ARTICLE
Piotr Domański, Mateusz Piętak, Barbara Kruczyk, Jadwiga Jarosińska, Anna Mydlak, Tomasz Demkow, Marta Darewicz, Bożena Sikora-Kupis, Paulina Dumnicka, Wojciech Kamzol, Jakub Kucharz
Cabozantinib, an oral inhibitor targeting MET, AXL, and VEGF receptors, has become a key component of a sequential treatment strategy for clear cell renal cell carcinoma (ccRCC). The purpose of this work is to show that effective management of adverse events (AEs) during cabozantinib treatment and achieving a balance between AEs and treatment efficacy is crucial to achieving therapeutic goals. In this retrospective study, involving seventy-one metastatic RCC (mRCC) patients receiving second or subsequent lines of cabozantinib at the Department of Genitourinary Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, we explored the impact of AEs on overall survival (OS) and progression-free survival (PFS)...
February 9, 2024: Biomedicines
https://read.qxmd.com/read/38386011/plasma-spd-l1-and-vegf-levels-are-associated-with-the-prognosis-of-nsclc-patients-treated-with-combination-immunotherapy
#31
JOURNAL ARTICLE
Changhong Dong, Kaiyuan Hui, Jie Gu, Mei Wang, Chenxi Hu, Xiaodong Jiang
The clinical significance of plasma soluble programmed cell death ligand 1 (sPD-L1) and vascular endothelial growth factor (VEGF) for non-small cell lung cancer (NSCLC) treated with the combination of anti-angiogenic therapy and anti-PD-L1 antibody (Ab) remain unknown. This study aimed to explore the association between plasma sPD-L1 and VEGF levels and the prognosis of NSCLC patients treated with the combination of Envafolimab and Endostar. Peripheral blood samples were collected from 24 NSCLC patients at baseline and after 6 weeks of treatment and were detected for sPD-L1 and VEGF levels...
February 23, 2024: Anti-cancer Drugs
https://read.qxmd.com/read/38374010/relationship-between-changes-of-serum-vascular-endothelial-growth-factor-and-folate-receptor-%C3%AE-levels-and-clinical-efficacy-of-toripalimab-in-patients-with-bladder-cancer
#32
JOURNAL ARTICLE
Rongfu Lin, Xinyang Fu, Jianhou Huang
OBJECTIVE: This study aims to explore the changes of serum vascular endothelial growth factor (VEGF) and folate receptor-α (FR-α) levels in patients with bladder cancer before and after treatment with toripalimab and to analyse the relationship between the changes of VEFG and FR-α and the clinical efficacy of patients. METHODS: A total of 176 patients with bladder cancer admitted to our hospital from January 2020 to January 2022 were selected as the research subjects...
January 2024: Archivos Españoles de Urología
https://read.qxmd.com/read/38372795/advanced-detection-of-cervical-cancer-biomarkers-using-engineered-filamentous-phage-nanofibers
#33
JOURNAL ARTICLE
Xu Zhou, Yicun Wang, Meijing Bao, Yuqing Chu, Ruixue Liu, Qi Chen, Yang Lin
Cervical cancer is a major global health concern, characterized by its high incidence and mortality rates. The detection of tumor markers is crucial for managing cancer, making treatment decisions, and monitoring disease progression. Vascular endothelial growth factor (VEGF) and programmed death-ligand 1 (PDL-1) are key targets in cervical cancer therapy and valuable biomarkers in predicting treatment response and prognosis. In this study, we found that combining the measurement of VEGF and soluble PDL-1 can be used for diagnosing and evaluating the progression of cervical cancer...
February 19, 2024: Applied Microbiology and Biotechnology
https://read.qxmd.com/read/38351273/proteinuria-frequency-and-subsequent-renal-dysfunction-in-bevacizumab-treated-patients-a-single-center-retrospective-observational-study
#34
JOURNAL ARTICLE
Shigeki Kataoka, Yoshitaka Nishikawa, Taro Funakoshi, Takahiro Horimatsu, Minoru Sakuragi, Eiichiro Uchino, Shusuke Hiragi, Shinya Yamamoto, Kaoru Sakai, Takeshi Matsubara, Motoko Yanagita, Manabu Muto
BACKGROUND: Proteinuria is a common adverse event observed during treatment with antivascular endothelial growth factor (VEGF) antibodies. Proteinuria is a risk factor for renal dysfunction and cardiovascular complications in patients with chronic kidney disease. However, the association between anti-VEGF antibody-induced proteinuria and renal dysfunction or cardiovascular complications remains unclear. METHODS: This retrospective, observational study included patients with cancer that were treated with bevacizumab (BV) at Kyoto University Hospital (Kyoto, Japan) between January 2006 and March 2018...
February 14, 2024: International Journal of Clinical Oncology
https://read.qxmd.com/read/38350547/s100a6-drives-lymphatic-metastasis-of-liver-cancer-via-activation-of-the-rage-nf-kb-vegf-d-pathway
#35
JOURNAL ARTICLE
TianYi Chen, YeLing Ruan, Lin Ji, JingWei Cai, Meng Tong, YangTao Xue, Hu Zhao, XiuJun Cai, JunJie Xu
Patients diagnosed with lymph node (LN) metastatic liver cancer face an exceedingly grim prognosis. In-depth analysis of LN metastatic patients' characteristics and tumor cells' interactions with human lymphatic endothelial cells (HLECs), can provide important biological and therapeutic insights. Here we identify at the single-cell level that S100A6 expression differs between primary tumor and their LN metastasis. Of particular significance, we uncovered the disparity in S100A6 expression between tumors and normal tissues is greater in intrahepatic cholangiocarcinoma (ICC) patients, frequently accompanied by LN metastases, than that in hepatocellular carcinoma (HCC), with rare occurrence of LN metastasis...
February 11, 2024: Cancer Letters
https://read.qxmd.com/read/38341583/pfkfb3-in-neovascular-eye-disease-unraveling-mechanisms-and-exploring-therapeutic-strategies
#36
REVIEW
Peiyu Liu, Dandan Sun, Shuchang Zhang, Shimei Chen, Xiaoqian Wang, Huiming Li, Fang Wei
BACKGROUND: Neovascular eye disease is characterized by pathological neovascularization, with clinical manifestations such as intraocular exudation, bleeding, and scar formation, ultimately leading to blindness in millions of individuals worldwide. Pathologic ocular angiogenesis often occurs in common fundus diseases including proliferative diabetic retinopathy (PDR), age-related macular degeneration (AMD), and retinopathy of prematurity (ROP). Anti-vascular endothelial growth factor (VEGF) targets the core pathology of ocular angiogenesis...
February 10, 2024: Cell & Bioscience
https://read.qxmd.com/read/38339353/t-cell-features-in-glioblastoma-may-guide-therapeutic-strategies-to-overcome-microenvironment-immunosuppression
#37
REVIEW
Agnese Losurdo, Antonio Di Muzio, Beatrice Claudia Cianciotti, Angelo Dipasquale, Pasquale Persico, Chiara Barigazzi, Beatrice Bono, Simona Feno, Federico Pessina, Armando Santoro, Matteo Simonelli
Glioblastoma (GBM) is the most aggressive and lethal primary brain tumor, bearing a survival estimate below 10% at five years, despite standard chemoradiation treatment. At recurrence, systemic treatment options are limited and the standard of care is not well defined, with inclusion in clinical trials being highly encouraged. So far, the use of immunotherapeutic strategies in GBM has not proved to significantly improve patients' prognosis in the treatment of newly diagnosed GBM, nor in the recurrent setting...
January 31, 2024: Cancers
https://read.qxmd.com/read/38334637/update-on-targeted-therapy-and-immunotherapy-for-metastatic-colorectal-cancer
#38
REVIEW
Patrick W Underwood, Samantha M Ruff, Timothy M Pawlik
Metastatic colorectal cancer remains a deadly malignancy and is the third leading cause of cancer-related death. The mainstay of treatment for metastatic colorectal cancer is chemotherapy, but unfortunately, even with recent progress, overall survival is still poor. Colorectal cancer is a heterogeneous disease, and the underlying genetic differences among tumors can define the behavior and prognosis of the disease. Given the limitations of cytotoxic chemotherapy, research has focused on developing targeted therapy based on molecular subtyping...
January 28, 2024: Cells
https://read.qxmd.com/read/38333032/cystoid-macular-edema-as-a-complication-of-central-retinal-artery-occlusion
#39
Rania Estawro, Neda Abraham, Yousef Fouad, Elodie Bousquet, David Sarraf
PURPOSE: To describe the development of cystoid macular edema (CME) as a complication of central retinal artery occlusion (CRAO) in 2 cases. OBSERVATIONS: The first patient was a 51-year-old female who presented with acute loss of vision in the left eye. Multimodal retinal imaging revealed a CRAO with a perfused cilioretinal artery. CME acutely developed one week after presentation. Cystoid spaces predominantly involved the outer nuclear layer (ONL) on optical coherence tomography (OCT) and completely resolved in two weeks...
March 2024: American Journal of Ophthalmology Case Reports
https://read.qxmd.com/read/38324117/predicting-clinical-progression-and-cognitive-decline-in-patients-with-relapsing-remitting-multiple-sclerosis-a-6-year-follow-up-study
#40
JOURNAL ARTICLE
Karolina Kania, Mikołaj A Pawlak, Maria Forycka, Monika Wiłkość-Dębczyńska, Sławomir Michalak, Agnieszka Łukaszewska, Aleksandra Wyciszkiewicz, Aleksandra Wypych, Zbigniew Serafin, Justyna Marcinkowska, Wojciech Kozubski, Alicja Kalinowska-Łyszczarz
INTRODUCTION: Cognitive impairment occurs from the earliest stages of multiple sclerosis (MS) and progresses over time. The introduction of disease modifying therapies (DMTs) has changed the prognosis for MS patients, offering a potential opportunity for improvement in the cognitive arena as well. MATERIAL AND METHODS: 41 patients with relapsing-remitting multiple sclerosis (MS) were recruited to the study. Thirty patients were available for final follow-up and were included in the analysis...
February 7, 2024: Neurologia i Neurochirurgia Polska
keyword
keyword
19145
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.